share_log

Verizon | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

SEC announcement ·  Jun 18 20:38
Summary by Futu AI
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities from Biodexa Pharmaceuticals Plc. The notification, which follows the provisions of Rule 12d2-2(a), states that the securities will be removed from listing and registration at the start of business on July 1, 2024. This action comes after the securities were redeemed or paid at maturity on June 18, 2024. Consequently, trading of Biodexa Pharmaceuticals' securities was suspended on the same day of redemption.
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities from Biodexa Pharmaceuticals Plc. The notification, which follows the provisions of Rule 12d2-2(a), states that the securities will be removed from listing and registration at the start of business on July 1, 2024. This action comes after the securities were redeemed or paid at maturity on June 18, 2024. Consequently, trading of Biodexa Pharmaceuticals' securities was suspended on the same day of redemption.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.